Applied DNA Sciences Stock Price, News & Analysis (NASDAQ:APDN) $0.88 -0.20 (-18.50%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$0.88▼$1.0050-Day Range$0.75▼$1.1452-Week Range$0.75▼$1.93Volume158,899 shsAverage Volume28,252 shsMarket Capitalization$12.03 millionP/E RatioN/ADividend YieldN/APrice Target$2.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Applied DNA Sciences MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside183.8% Upside$2.50 Price TargetShort InterestHealthy2.30% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.21Based on 7 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.90 out of 5 starsIndustrial Products Sector111th out of 176 stocksMiscellaneous Business Services Industry3rd out of 6 stocks 3.5 Analyst's Opinion Consensus RatingApplied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.50, Applied DNA Sciences has a forecasted upside of 183.8% from its current price of $0.88.Amount of Analyst CoverageApplied DNA Sciences has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.30% of the outstanding shares of Applied DNA Sciences have been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 9.5.Change versus previous monthShort interest in Applied DNA Sciences has recently decreased by 3.69%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldApplied DNA Sciences does not currently pay a dividend.Dividend GrowthApplied DNA Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for APDN. Previous Next 2.3 News and Social Media Coverage News SentimentApplied DNA Sciences has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Industrial Products companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Applied DNA Sciences this week, compared to 1 article on an average week.Search Interest3 people have searched for APDN on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.83% of the stock of Applied DNA Sciences is held by insiders.Percentage Held by InstitutionsOnly 17.34% of the stock of Applied DNA Sciences is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied DNA Sciences is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied DNA Sciences is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied DNA Sciences has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Applied DNA Sciences Stock (NASDAQ:APDN)Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.Read More APDN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APDN Stock News HeadlinesDecember 9, 2023 | americanbankingnews.comApplied DNA Sciences (NASDAQ:APDN) Given New $2.00 Price Target at HC WainwrightDecember 8, 2023 | benzinga.comApplied DNA Sciences Stock (NASDAQ:APDN), Quotes and News SummaryDecember 9, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comDecember 7, 2023 | finance.yahoo.comApplied DNA Announces Fourth Quarter Fiscal Year 2023 Financial ResultsDecember 7, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Applied DNA Sciences (NASDAQ:APDN)December 5, 2023 | finance.yahoo.comApplied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023November 29, 2023 | americanbankingnews.comApplied DNA Sciences (NASDAQ:APDN) Coverage Initiated by Analysts at StockNews.comNovember 28, 2023 | finance.yahoo.comApplied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic ApplicationDecember 9, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 16, 2023 | finance.yahoo.comApplied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)November 9, 2023 | finance.yahoo.comApplied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA PlatformNovember 5, 2023 | morningstar.comApplied DNA Sciences Inc APDNSeptember 14, 2023 | finance.yahoo.comApplied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value AnimalsSeptember 6, 2023 | finance.yahoo.comApplied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP ProgramsSeptember 6, 2023 | finance.yahoo.comApplied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP ProgramsAugust 29, 2023 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Announces Availability and First Customer Shipment of New Linea IVT Evaluation KitAugust 29, 2023 | finance.yahoo.comApplied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation KitAugust 24, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Technology Stocks: Autodesk (ADSK), Applied DNA Sciences (APDN)August 23, 2023 | finance.yahoo.comApplied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA ProductionAugust 11, 2023 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate UpdateAugust 11, 2023 | finance.yahoo.comApplied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate UpdateAugust 9, 2023 | benzinga.comEarnings Preview: Applied DNA SciencesAugust 8, 2023 | finance.yahoo.comADT (ADT) Q2 Earnings and Revenues Miss EstimatesAugust 7, 2023 | finance.yahoo.comApplied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023August 4, 2023 | finance.yahoo.com3 Penny Stocks to Buy Before the BreakoutJuly 18, 2023 | finanznachrichten.deApplied DNA Sciences, Inc.: Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry ConferencesJuly 14, 2023 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Applied DNA Sciences (APDN) and Mogo Finance Technology (MOGO)See More Headlines Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/07/2023Today12/09/2023Next Earnings (Estimated)2/08/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Miscellaneous business services Sub-IndustryN/A SectorIndustrial Products Current SymbolNASDAQ:APDN CUSIPN/A CIK744452 Webwww.adnas.com Phone(631) 240-8800Fax631-240-8900Employees61Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$3.00 Low Stock Price Target$2.00 Potential Upside/Downside+183.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.75) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,270,000.00 Net Margins-74.41% Pretax Margin-43.79% Return on Equity-126.68% Return on Assets-60.33% Debt Debt-to-Equity RatioN/A Current Ratio4.23 Quick Ratio4.14 Sales & Book Value Annual Sales$13.37 million Price / Sales0.90 Cash FlowN/A Price / Cash FlowN/A Book Value$1.08 per share Price / Book0.82Miscellaneous Outstanding Shares13,660,000Free Float12,726,000Market Cap$12.03 million OptionableOptionable Beta0.63 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. James A. Hayward Ph.D. (Age 69)Sc.D., Chairman, President & CEO Comp: $1.27MMs. Beth M. Jantzen CPA (Age 47)Chief Financial Officer Comp: $390kMs. Judith Murrah (Age 65)COO, Chief Information Officer & Secretary Comp: $438.75kMr. Sanjay M. HurryExecutive Director of Investor Relations & Corporate CommunicationsMr. Clay Shorrock Esq. (Age 38)J.D., Chief Legal Officer & Executive Director of Business Development Mr. Tony BensonManaging Director of EMEAMr. Joseph L. MagnoSales ConsultantMr. Warren PearlsonSales ConsultantMore ExecutivesKey CompetitorsMeta DataNYSE:AIUEuro TechNASDAQ:CLWTFitellNASDAQ:FTELurban-groNASDAQ:UGROSarcos Technology and RoboticsNASDAQ:STRCView All CompetitorsInstitutional OwnershipSabby Management LLCBought 389 shares on 11/15/2023Ownership: 0.000%AMH Equity LtdBought 254,232 shares on 11/6/2023Ownership: 4.299%View All Institutional Transactions APDN Stock Analysis - Frequently Asked Questions Should I buy or sell Applied DNA Sciences stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" APDN shares. View APDN analyst ratings or view top-rated stocks. What is Applied DNA Sciences' stock price target for 2024? 1 brokers have issued 12-month target prices for Applied DNA Sciences' stock. Their APDN share price targets range from $2.00 to $3.00. On average, they anticipate the company's share price to reach $2.50 in the next year. This suggests a possible upside of 183.8% from the stock's current price. View analysts price targets for APDN or view top-rated stocks among Wall Street analysts. How have APDN shares performed in 2023? Applied DNA Sciences' stock was trading at $1.66 at the start of the year. Since then, APDN stock has decreased by 46.9% and is now trading at $0.8810. View the best growth stocks for 2023 here. When is Applied DNA Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024. View our APDN earnings forecast. How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences, Inc. (NASDAQ:APDN) posted its quarterly earnings data on Thursday, December, 7th. The technology company reported ($0.26) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.01. The technology company had revenue of $0.78 million for the quarter, compared to analyst estimates of $1.60 million. Applied DNA Sciences had a negative net margin of 74.41% and a negative trailing twelve-month return on equity of 126.68%. What is James A. Hayward's approval rating as Applied DNA Sciences' CEO? 2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend. What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC). Who are Applied DNA Sciences' major shareholders? Applied DNA Sciences' stock is owned by a variety of retail and institutional investors. Top institutional investors include AMH Equity Ltd (4.30%), Sabby Management LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). View institutional ownership trends. How do I buy shares of Applied DNA Sciences? Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:APDN) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.